I realize that many Medtronics employees are heart sick over this situation. I extend my sympathies to them. I once had the honor of visiting with Earl Bakken in my lab on a snowy morning when we were the only ones who made it into work. I took the bus, and he crossed the street from the Radisson. Medtronic is a wonderful company and this situation is disgraceful. My bet is that the people responsible for this will soon be gone. Live long and prosper, Medtronic. Our state depends on innovative companies like yours.

Something remarkable has happened. A whole issue—June—of a prominent journal, The Spine Journal, is devoted to destroying industry-funded research supporting the use of a bio-therapeutic agent for spinal fusion, so-called recombinant human bone morphogenetic protein form 2 (rhBMP-2) in the Medtronic product, Infuse.

This remarkable issue features an editorial that is available for download as a pdf: “A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors.” It initially cites seven research publications for scrutiny. Altogether these studies report zero, nada, side effects in 780 protocol patients. The authors dryly add another citation (from Hemingway’s The Sun Also Rises) to the list: “Yes, isn’t it pretty to think so.”

Since then the side-effects of rhBMP-2 have become widely known. These include conditions related to unregulated bone growth as well as other disorders including sterility in males and cancer.

And what did these criticized studies have in common: Megabucks for the investigators from, primarily, Medtronic. Some of the authors of these studies have financial involvements with Medtronic that run in the tens of millions of dollars.

The writers of this piece were really on their game. They point out that one of the openings often used by these shills is the choirboy defense: “We are an honest profession; our integrity is unimpeachable; our ethical standards are not in doubt; potential conflicts of interest are only ‘potential’…” I’ve heard these same arguments used by three medical-school deans so far.

The editorial ends with the primum non nocere statement of the Hippocratic Oath. First do no harm. It admits that harm has been done. At first I was a little disappointed in this argument, but on reflection it really is that simple. I’ve heard a medical school dean justify behavior based on the fact that something was not illegal.

Bill Gleason is an Associate Professor at the University of Minnesota in the Department of Laboratory Medicine and Pathology. He's also a fellow at the U's Supercomputer Institute. Read more about Gleason.

The University of Minnesota administration would like to dodge ethical responsibilities in the Markingson case in which a young man committed suicide while participating in a clinical trial. This is unwise.

The University of Minnesota administration continues to stonewall on the Markingson suicide case, which occurred during a clinical trial there. They claim that nothing wrong has been done. This is simply not true.